✦ LIBER ✦

BCR-ABL mutations and resistance to imatinib mesylate in Ph+ leukaemia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose increase of imatinib mesylate may o

✍ Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Marilina Amabile; Stefa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Overproduction of BCR-ABL induces apopto

✍ Vanessa Desplat; Francis Belloc; Valérie Lagarde; Catherine Boyer; Junia V. Melo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Increasing the BCR-ABL expression levels

✍ S. Grammatico; L. Elia; A.L. Peluso; L. Pedace; M. Matarazzo; A. Vitale; A. Rago 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

628 Targeting Bcr/Abl and Src family kin

✍ J.Y. Wu; M. Talpaz; J. Stapley; S. Lee; N. Donato 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Resistance to imatinib mesylate in chron

✍ Junia V. Melo; Charles Chuah 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Galangin increases the cytotoxic activit

✍ Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Rosaria M. Pipitone; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 421 KB